2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL7801065

Nc1nc(N)c2[nH]cnc2n1.OC[C@H]1OC(O)C[C@@H]1O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.55
GDA Q9Y2T3 1/20 0.55
ADRB1 P08588 1/20 0.40
DNMT1 P26358 1/20 0.40
CDK2 P24941 12/20 0.40
DPP4 P27487 1/20 0.40
CDK1 P06493 11/20 0.39
CCNB1 P14635 11/20 0.39
CCNA2 P20248 11/20 0.39
CCNA1 P78396 11/20 0.39
MAP3K5 Q99683 2/20 0.39
PIN1 Q13526 2/20 0.39
CCNB2 O95067 1/20 0.39
MAPK3 P27361 1/20 0.39
CLK1 P49759 1/20 0.39
CDK5 Q00535 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
MGMT P16455 6/20 0.38
PNP P00491 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,6-Diaminopurine SCHEMBL10774603 0.81 PDPK1 (0.59) PDPK1GDADNMT1CDK2DPP4
2,6-Diaminopurine SCHEMBL2934952 0.81 PDPK1 (0.59) PDPK1GDADNMT1CDK2DPP4
2,6-Diaminopurine SCHEMBL6241914 0.81 PDPK1 (0.59) PDPK1GDADNMT1CDK2DPP4
SCHEMBL7646510 0.81 PDPK1 (0.41) PDPK1GDAADRB1DNMT1CDK2
2-Aminopurine SCHEMBL1919609 0.81 ALDH1A1 (0.55) PDPK1GDAADRB1DNMT1CDK2
2,6-Diaminopurine SCHEMBL443468 0.81 PDPK1 (0.55) PDPK1GDACDK2DPP4CDK1
2,6-Diaminopurine SCHEMBL2586310 0.80 PDPK1 (0.56) PDPK1GDACDK2DPP4CDK1
SCHEMBL7661702 0.78 BRAF (0.43) PDPK1GDACDK1
Doxribtimine SCHEMBL2195275 0.77 TK1 (0.52) LMNASMN1; SMN2
2,6-Diaminopurine SCHEMBL28189513 0.76 ADRB1 (0.41) PDPK1GDAADRB1DNMT1MGMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074611-A Method and polynucleotide for amplifying target polynucleotide 牛津纳米孔科技公司 2020-12-11 CN disclosed
EP-1163251-A1 N-ACYLPHOSPHORAMIDITES AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2001-12-19 EP disclosed
WO-2000056749-A1 N-ACYLPHOSPHORAMIDITES AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-09-28 WO disclosed
US-5166315-A Polynucleotides for genetic engineering ANTI-GENE DEVELOPMENT GROUP (US) 1992-11-24 US disclosed